Susumu Tanimura Selected Research

Susumu Tanimura Research Topics

Disease

17	Neoplasms (Cancer) 03/2017 - 05/2003
2	Hypertension (High Blood Pressure) 01/2021 - 01/2016
2	Rupture 01/2021 - 01/2019
2	Obesity 12/2016 - 04/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 09/2012
2	Fibrosarcoma 07/2011 - 05/2005
2	Cysts 04/2009 - 06/2006
1	Autoimmune Diseases (Autoimmune Disease) 06/2022
1	Familial Mediterranean Fever (Periodic Disease) 06/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Human Influenza (Influenza) 01/2021
1	Glioma (Gliomas) 03/2017
1	Leukemia 03/2017
1	Inflammation (Inflammations) 12/2016
1	Type 2 Diabetes Mellitus (MODY) 04/2016
1	Insulin Resistance 04/2016
1	Hyperglycemia 04/2016
1	Hyperlipidemias (Hyperlipidemia) 04/2016
1	Hypertrophy 04/2016
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 12/2013
1	Carcinoma (Carcinomatosis) 07/2011
1	Breast Neoplasms (Breast Cancer) 07/2011
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2010
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2010
1	Pneumococcal Pneumonia 07/2006
1	Pneumonia (Pneumonitis) 07/2006
1	Disease Progression 06/2006
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 06/2006
1	Neoplasm Metastasis (Metastasis) 05/2005

Drug/Important Bio-Agent (IBA)

7	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2016 - 05/2003
7	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2016 - 04/2009
6	2- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamideIBA 04/2016 - 05/2003
4	Histone Deacetylase InhibitorsIBA 04/2013 - 02/2008
3	Pharmaceutical PreparationsIBA 06/2022 - 07/2004
3	SaltsIBA 01/2021 - 09/2012
3	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 03/2012 - 05/2003
2	Proteins (Proteins, Gene)FDA Link 06/2022 - 05/2003
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021 - 01/2019
2	Tubulin ModulatorsIBA 07/2011 - 08/2007
2	DNA (Deoxyribonucleic Acid)IBA 02/2008 - 02/2006
2	Matrix Metalloproteinases (MMPs)IBA 05/2005 - 05/2003
1	Monoclonal AntibodiesIBA 06/2022
1	Single-Domain AntibodiesIBA 06/2022
1	Granzymes (Granzyme)IBA 01/2021
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2021
1	alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA 03/2017
1	WP1066IBA 03/2017
1	ruxolitinibIBA 03/2017
1	InflammasomesIBA 03/2017
1	Cysteine Proteases (Cysteine Protease)IBA 12/2016
1	Leptin ReceptorsIBA 04/2016
1	Phosphotransferases (Kinase)IBA 04/2016
1	AdipokinesIBA 04/2016
1	Glucose (Dextrose)FDA LinkGeneric 04/2016
1	mirdametinibIBA 04/2016
1	Antihypertensive Agents (Antihypertensives)IBA 01/2016
1	Nicotine FDA Link 12/2013
1	Chewing Gum (Chewing Gums)IBA 12/2013
1	AZD 6244IBA 04/2013
1	Histone Deacetylases (Histone Deacetylase)IBA 04/2013
1	entinostat (MS 275)IBA 04/2013
1	Apoptosis Regulatory ProteinsIBA 03/2012
1	NCX 4040IBA 07/2011
1	1- (4- chlorobenzoyl)- 5- methoxy- 2- 1H- indole- 3- acetic acid 3-(nitrooxymethyl)phenyl esterIBA 07/2011
1	TubulinIBA 07/2011
1	Phenol (Carbolic Acid)FDA Link 07/2011
1	Vincristine (Oncovin)FDA LinkGeneric 07/2011
1	aniline (aniline hydrobromide)IBA 07/2011
1	BI D1870IBA 05/2011
1	Antineoplastic Agents (Antineoplastics)IBA 01/2011
1	soblidotin (TZT 1027)IBA 02/2010
1	Vinorelbine (Navelbine)FDA LinkGeneric 02/2010
1	ErbB Receptors (EGF Receptor)IBA 01/2010
1	Imatinib Mesylate (Gleevec)FDA Link 01/2010
1	Gefitinib (Iressa)FDA Link 01/2010
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2010
1	Cytostatic AgentsIBA 01/2010
1	Bromodeoxyuridine (BrdU)IBA 04/2009
1	Protein Kinases (Protein Kinase)IBA 04/2009
1	DeoxyuridineIBA 04/2009
1	Histones (Histone)IBA 02/2008
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2008
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2007
1	CathepsinsIBA 12/2007
1	MacrolidesIBA 07/2006
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 06/2006
1	Mitogen-Activated Protein KinasesIBA 06/2006
1	p38 Mitogen-Activated Protein KinasesIBA 06/2006
1	JNK Mitogen-Activated Protein KinasesIBA 06/2006
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 02/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2006
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 02/2006
1	TeaIBA 05/2005
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 05/2005
1	Hydrolyzable TanninsIBA 05/2005
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 05/2005
1	beta-d-glucoseIBA 05/2005
1	1,2,4- tri- O- galloyl- 3,6- hexahydroxydiphenoylglucoseIBA 05/2005

Therapy/Procedure

2	Therapeutics 06/2022 - 01/2011
1	Oral Administration 04/2016